These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 19534587)

  • 1. Effect of sodium tanshinone II A sulfonate on the activity of CYP1A2 in healthy volunteers.
    Chen Y; Tu JH; He YJ; Zhang W; Wang G; Tan ZR; Zhou G; Fan L; Zhou HH
    Xenobiotica; 2009 Jul; 39(7):508-13. PubMed ID: 19534587
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics of caffeine in plasma and saliva, and the influence of caffeine abstinence on CYP1A2 metrics.
    Perera V; Gross AS; Xu H; McLachlan AJ
    J Pharm Pharmacol; 2011 Sep; 63(9):1161-8. PubMed ID: 21827488
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Caffeine and paraxanthine HPLC assay for CYP1A2 phenotype assessment using saliva and plasma.
    Perera V; Gross AS; McLachlan AJ
    Biomed Chromatogr; 2010 Oct; 24(10):1136-44. PubMed ID: 20853468
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of major tanshinones isolated from Danshen (Salvia miltiorrhiza) on rat CYP1A2 expression and metabolism of model CYP1A2 probe substrates.
    Wang X; Lee WY; Or PM; Yeung JH
    Phytomedicine; 2009 Aug; 16(8):712-25. PubMed ID: 19403289
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Omeprazole weakly inhibits CYP1A2 activity in man.
    Rost KL; Fuhr U; Thomsen T; Zaigler M; Brockmöller J; Bohnemeier H; Roots I
    Int J Clin Pharmacol Ther; 1999 Nov; 37(11):567-74. PubMed ID: 10584979
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interaction of pefloxacin and enoxacin with the human cytochrome P450 enzyme CYP1A2.
    Kinzig-Schippers M; Fuhr U; Zaigler M; Dammeyer J; Rüsing G; Labedzki A; Bulitta J; Sörgel F
    Clin Pharmacol Ther; 1999 Mar; 65(3):262-74. PubMed ID: 10096258
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The paraxanthine:caffeine ratio in serum or in saliva as a measure of CYP1A2 activity: when should the sample be obtained?
    Spigset O; Hägg S; Söderström E; Dahlqvist R
    Pharmacogenetics; 1999 Jun; 9(3):409-12. PubMed ID: 10471076
    [No Abstract]   [Full Text] [Related]  

  • 8. Assessment of CYP1A2 activity in clinical practice: why, how, and when?
    Faber MS; Jetter A; Fuhr U
    Basic Clin Pharmacol Toxicol; 2005 Sep; 97(3):125-34. PubMed ID: 16128905
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ciprofloxacin greatly increases concentrations and hypotensive effect of tizanidine by inhibiting its cytochrome P450 1A2-mediated presystemic metabolism.
    Granfors MT; Backman JT; Neuvonen M; Neuvonen PJ
    Clin Pharmacol Ther; 2004 Dec; 76(6):598-606. PubMed ID: 15592331
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of venlafaxine on CYP1A2-dependent pharmacokinetics and metabolism of caffeine.
    Amchin J; Zarycranski W; Taylor KP; Albano D; Klockowski PM
    J Clin Pharmacol; 1999 Mar; 39(3):252-9. PubMed ID: 10073324
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Validation of a high-performance liquid chromatography assay for quantification of caffeine and paraxanthine in human serum in the context of CYP1A2 phenotyping.
    Koch JP; ten Tusscher GW; Koppe JG; Guchelaar HJ
    Biomed Chromatogr; 1999 Jun; 13(4):309-14. PubMed ID: 10416066
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Time response of cytochrome P450 1A2 activity on cessation of heavy smoking.
    Faber MS; Fuhr U
    Clin Pharmacol Ther; 2004 Aug; 76(2):178-84. PubMed ID: 15289794
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A pharmacometric approach to investigate the impact of methylxanthine abstinence and caffeine consumption on CYP1A2 activity.
    Perera V; Gross AS; Forrest A; Landersdorfer CB; Xu H; Ait-Oudhia S; McLachlan AJ
    Drug Metab Dispos; 2013 Nov; 41(11):1957-66. PubMed ID: 23996078
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Simultaneous action of the flavonoid quercetin on cytochrome P450 (CYP) 1A2, CYP2A6, N-acetyltransferase and xanthine oxidase activity in healthy volunteers.
    Chen Y; Xiao P; Ou-Yang DS; Fan L; Guo D; Wang YN; Han Y; Tu JH; Zhou G; Huang YF; Zhou HH
    Clin Exp Pharmacol Physiol; 2009 Aug; 36(8):828-33. PubMed ID: 19215233
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Paraxanthine/Caffeine Concentration Ratios in Hair: An Alternative for Plasma-Based Phenotyping of Cytochrome P450 1A2?
    De Kesel PM; Lambert WE; Stove CP
    Clin Pharmacokinet; 2015 Jul; 54(7):771-81. PubMed ID: 25603821
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of the aqueous extract from Salvia miltiorrhiza Bunge on caffeine pharmacokinetics and liver microsomal CYP1A2 activity in humans and rats.
    Wang X; Yeung JH
    J Pharm Pharmacol; 2010 Aug; 62(8):1077-83. PubMed ID: 20663043
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Artemisinin and thiabendazole are potent inhibitors of cytochrome P450 1A2 (CYP1A2) activity in humans.
    Bapiro TE; Sayi J; Hasler JA; Jande M; Rimoy G; Masselle A; Masimirembwa CM
    Eur J Clin Pharmacol; 2005 Nov; 61(10):755-61. PubMed ID: 16261361
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rofecoxib is a potent inhibitor of cytochrome P450 1A2: studies with tizanidine and caffeine in healthy subjects.
    Backman JT; Karjalainen MJ; Neuvonen M; Laitila J; Neuvonen PJ
    Br J Clin Pharmacol; 2006 Sep; 62(3):345-57. PubMed ID: 16934051
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rifampicin is only a weak inducer of CYP1A2-mediated presystemic and systemic metabolism: studies with tizanidine and caffeine.
    Backman JT; Granfors MT; Neuvonen PJ
    Eur J Clin Pharmacol; 2006 Jun; 62(6):451-61. PubMed ID: 16758262
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Profiling the metabolic difference of seven tanshinones using high-performance liquid chromatography/multi-stage mass spectrometry with data-dependent acquisition.
    Sun J; Yang M; Han J; Wang B; Ma X; Xu M; Liu P; Guo D
    Rapid Commun Mass Spectrom; 2007; 21(14):2211-26. PubMed ID: 17569103
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.